GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139 | +9.4% | 80,535 | +24.4% | 0.00% | – |
| Q2 2023 | $127 | -3.1% | 64,735 | +38.0% | 0.00% | – |
| Q1 2023 | $131 | +1.6% | 46,900 | +25.7% | 0.00% | – |
| Q4 2022 | $129 | -99.9% | 37,300 | 0.0% | 0.00% | – |
| Q3 2022 | $96,000 | +6.7% | 37,300 | 0.0% | 0.00% | – |
| Q2 2022 | $90,000 | -46.7% | 37,300 | -9.2% | 0.00% | – |
| Q1 2022 | $169,000 | -54.6% | 41,099 | +41.9% | 0.00% | – |
| Q4 2021 | $372,000 | +10.7% | 28,956 | -7.0% | 0.00% | – |
| Q3 2021 | $336,000 | -81.9% | 31,144 | -84.7% | 0.00% | – |
| Q2 2021 | $1,861,000 | -36.6% | 203,870 | -34.6% | 0.00% | – |
| Q1 2021 | $2,937,000 | +19.0% | 311,495 | -16.2% | 0.00% | – |
| Q2 2020 | $2,468,000 | +4.1% | 371,757 | -8.7% | 0.00% | – |
| Q1 2020 | $2,371,000 | +32.3% | 407,322 | +103.9% | 0.00% | – |
| Q4 2019 | $1,792,000 | – | 199,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |